Biotech
Vertex Pharmaceuticals
Vertex transformed cystic fibrosis treatment with its CFTR modulator franchise and is expanding into pain, kidney disease, and gene-edited cell therapies. It collaborates with the Cystic Fibrosis Foundation and academic labs on structure-based drug design.
$3.3B R&D Spend
Biotech Industry
180 Academic Collaborations
4,200 Patents
Industry
Biotech →Researchers connected to Vertex Pharmaceuticals
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →